• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Ethris` inhaled mRNA-based asthma drug ups its target protein without toxicity

    FIERCE BIOTECH

    Cipla EU to invest an additional € 3 million in Ethris

    INDIANPHARMAPOST

    Ethris Announces $5M Funding To Prepare ETH47 For Phase 2 Study

    BUSINESSWIRE

    Ethris Initiates First-in-Human Dosing in Phase 1 Study of ETH47

    GLOBENEWSWIRE

    Ethris and Heqet Therapeutics Announce Collaboration

    GLOBENEWSWIRE

    Ethris Joins Alliance for mRNA Medicines as a Founding Member

    GLOBENEWSWIRE

    DIOSynVax & Ethris Publish Preclinical Proof of Concept for Vaccine Technologies

    GLOBENEWSWIRE

    Cipla EU to Invest EUR 15 m in Ethris, initiating a strategic collaboration

    PR NEWSWIRE

    Ethris Announces Collaboration with DIOSynVax and CEPI

    BUSINESSWIRE

    Ethris Raises $26.3M Series B to Advance mRNA-based Therapeutics

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.